ClinVar Miner

Submissions for variant NM_000059.4(BRCA2):c.6016A>G (p.Ser2006Gly)

dbSNP: rs2072544288
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001899375 SCV002128630 uncertain significance Hereditary breast ovarian cancer syndrome 2021-07-28 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BRCA2 protein function. This variant has not been reported in the literature in individuals affected with BRCA2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with glycine at codon 2006 of the BRCA2 protein (p.Ser2006Gly). The serine residue is weakly conserved and there is a small physicochemical difference between serine and glycine.
Ambry Genetics RCV002359323 SCV002656211 uncertain significance Hereditary cancer-predisposing syndrome 2021-11-22 criteria provided, single submitter clinical testing The p.S2006G variant (also known as c.6016A>G), located in coding exon 10 of the BRCA2 gene, results from an A to G substitution at nucleotide position 6016. The serine at codon 2006 is replaced by glycine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
University of Washington Department of Laboratory Medicine, University of Washington RCV002359323 SCV003850860 likely benign Hereditary cancer-predisposing syndrome 2023-03-23 criteria provided, single submitter curation Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.